000 01327 a2200337 4500
005 20250515122037.0
264 0 _c20080930
008 200809s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/bjp.2008.204
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJensen, B M
245 0 0 _aPharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cAug 2008
300 _a1572-82 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnaphylaxis
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aMastocytosis
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins c-kit
_xdrug effects
650 0 4 _aStem Cell Factor
_xmetabolism
700 1 _aAkin, C
700 1 _aGilfillan, A M
773 0 _tBritish journal of pharmacology
_gvol. 154
_gno. 8
_gp. 1572-82
856 4 0 _uhttps://doi.org/10.1038/bjp.2008.204
_zAvailable from publisher's website
999 _c17993976
_d17993976